Aigen Investment Management’s Twist Bioscience TWST Stock Holding History

Aigen Investment Management’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$236K	Buy	+2,290	New	+$149K	0.06%	385
2025 Q4	–	Sell	-15,212	Closed	-$428K	–	989
2025 Q3	$428K	Buy	+15,212	New	+$461K	0.07%	436
2025 Q1	–	Sell	-6,376	Closed	-$296K	–	1041
2024 Q4	$296K	Sell	6,376 -2,661	-29%	-$120K	0.05%	482
2024 Q3	$408K	Buy	9,037 +4,125	+84%	+$196K	0.08%	378
2024 Q2	$242K	Sell	4,912 -5,591	-53%	-$228K	0.05%	562
2024 Q1	$360K	Buy	10,503 +3,895	+59%	+$141K	0.08%	374
2023 Q4	$244K	Buy	+6,608	New	+$153K	0.04%	580
2022 Q1	–	Sell	-2,910	Closed	-$243K	–	1089
2021 Q4	$243K	Buy	+2,910	New	+$299K	0.01%	866
2021 Q2	–	Sell	-24,068	Closed	-$2.98M	–	738
2021 Q1	$2.98M	Buy	+24,068	New	+$3.65M	0.39%	65

Other funds holding TWST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Aigen Investment Management's TWST Position: Q2 2026 in Review

Aigen Investment Management opened a new position in Twist Bioscience (TWST) in Q2 2026: 2,290 shares worth $236K. The stake represents 0.06% of the portfolio and ranks #385 among its holdings. This is a return to the name: Aigen Investment Management previously reported a position in TWST as recently as Q3 2025.

Aigen Investment Management first reported a position in TWST in Q1 2021 and has held it in 9 quarters since. The position peaked at $2.98M in Q1 2021. 337 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

Aigen Investment Management held 2,290 shares of Twist Bioscience worth $236K as of Q2 2026.
Twist Bioscience was a new Aigen Investment Management position in Q2 2026.
Twist Bioscience made up 0.06% of Aigen Investment Management's portfolio in Q2 2026, its #385 holding.
Aigen Investment Management first reported a position in Twist Bioscience in Q1 2021 and has held it in 9 quarters since.
Aigen Investment Management's Twist Bioscience position peaked at $2.98M in Q1 2021.
337 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Aigen Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.